Tenaya Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference
SOUTH SAN FRANCISCO, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver pot...
Will the conference discussion impact the stock's volatility and trading volume on the day of the event?
How might the market's perception of Tenaya's CEO leadership influence investor sentiment after the conference?
Is there any risk of negative disclosure (e.g., trial setbacks, regulatory issues) that could be revealed during the talk?
18 days ago